Leukocyte immunoglobulin-like receptor: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
===LIR-1=== | |||
[[1g0x]], [[1ufu]] – hLIR ligand-binding domain – human <br /> | [[1g0x]], [[1ufu]] – hLIR ligand-binding domain – human <br /> | ||
[[1ugn]], [[1vdg]] – hLIR ligand-binding domain (mutant) <br /> | [[1ugn]], [[1vdg]] – hLIR ligand-binding domain (mutant) <br /> | ||
===LIR-1 complexes=== | |||
[[1p7q]] – hLIR ligand-binding domain + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | [[1p7q]] – hLIR ligand-binding domain + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | ||
[[3d2u]] – hLIR ligand-binding domain + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | [[3d2u]] – hLIR ligand-binding domain + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||